BioScrip Cash Flow - Annual (NASDAQ:BIOS)

Add to My Stocks
$2.99 $0.11 (3.55%) BIOS stock closing price Aug 16, 2017 (Closing)

The BioScrip cash flow statement is one of the three reports that the company generates every quarter. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about BioScrip profits and BioScrip debt. BioScrip cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  BioScrip had cash and cash equivalents of $15.57M at the beginning of the year and $9.56M at year end for 2016.   BioScrip had an inflow of $21.98M from operating activities, $43.19M inflow due to financing activities, and $86M spend due to investing activities for 2016. View details of BioScrip cash flows for latest & last ten financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
BioScrip Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow25.59M26.18M27.09M22.48M13.73M16.93M14.14M5.03M100.27M7.09M
Net Increase (Decrease) in Assets Liabilities-11.43M-21.28M75.74M-32.43M38.19M-3.85M-26.98M-7.8M-31.22M5.65M
Cash From (used in) Discontinued Operations-0.42M-6.17M-2.68M--96.02M-----
Other Adjustments Net-14.99M236.24M15.89M25.05M6.27M6.02M60.56M-28.58M-3.76M8.12M
BioScrip Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-5.46M-11.54M-13.82M-25.62M-10.98M-9.44M-11.11M-5.73M-7.46M-5.52M
Acquisition Disposition of Subsidiaires-67.51M--0.45M-282.99M-45.98M-0.46M-97.43M---
Increase (Decrease) in Investments--0.85M8.61M------
Other Cash Inflow (Outflow) from Investment Activities-24.56M57.68M-2.36M150.84M-----
BioScrip Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares83.06M59.58M1.1M120.93M8.43M3M3.98M2.89M-0.42M1.86M
Issuance (Repayment) of Debt Securities-13.62M-0.39M21.93M134.89M-3.27M-2.63M89.96M---
Increase (Decrease) in Bank & Other Borrowings40.3M10M-35M40M-63.82M-17.41M48.59M-20.02M16.63M-19.13M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--2.63M-1.13M---0.02M-12.58M0.12M--1.39M
BioScrip Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
BioScrip Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year15.57M0.74M1M62.1M------
Cash & Equivalents at Year End9.56M15.57M0.74M1M62.1M-----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

BioScrip stock comparison chart provides an easy way to compare the stock price with peers along with details of BioScrip stock price history.
The statement of cash flows can be categorized into three main sections:
  • BioScrip had a Net Change in Cash and Cash Equivalents of $-6M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the BioScrip stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: BioScrip reported a negative operating cash flow of $-42.76M for 2016 and has seen an increase from the previous year. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-72.98M for BIOS stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between BioScrip and its owners and creditors and was $109.74M for 2016. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For BioScrip Cash Flow

FCF margin